A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer
Clinical trial NCT04958473 · UNKNOWN
Trial details
- NCT number
- NCT04958473
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.